Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 58, Issue 10, Pages 4278-4290Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.5b00257
Keywords
-
Categories
Ask authors/readers for more resources
An empirical approach to improve the microsomal stability and CYP inhibition profile of lead compounds 1a and 1b led to the identification of 5 (BMS-341) as a dissociated glucocorticoid receptor modulator. Compound 5 showed significant improvements in pharmacokinetic properties and, unlike compounds 1a-b, displayed a linear, dose-dependent pharmacokinetic profile in rats. When tested in a chronic model of adjuvant-induced arthritis in rat, the ED50 of 5 (0.9 mg/kg) was superior to that of both 1a and 1b (8 and 17 mg/kg, respectively).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available